54 related articles for article (PubMed ID: 18368476)
1. Altered expression of anti-apoptotic proteins in non-involved tissue from cancer-containing breasts.
Batchelder AJ; Gordon-Weeks AN; Walker RA
Breast Cancer Res Treat; 2009 Mar; 114(1):63-9. PubMed ID: 18368476
[TBL] [Abstract][Full Text] [Related]
2. Decreased apoptosis in non-involved tissue from cancer-containing breasts.
Hassan HI; Walker RA
J Pathol; 1998 Mar; 184(3):258-64. PubMed ID: 9614377
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of epidermal growth factor receptor in non-involved tissue of cancer-containing breasts.
Hassan HI; Walker RA
Breast; 2001 Aug; 10(4):318-24. PubMed ID: 14965601
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
5. Frequency analysis of apoptosis in sporadic breast cancer.
Kozłowska E; Smolarz B; Kulig A; Romanowicz-Makowska H
Pol J Pathol; 2006; 57(4):199-204. PubMed ID: 17285763
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells.
Cucina A; Proietti S; D'Anselmi F; Coluccia P; Dinicola S; Frati L; Bizzarri M
J Pineal Res; 2009 Mar; 46(2):172-80. PubMed ID: 19175854
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
8. The expression and function of IGFBP-3 in normal and malignant breast tissue.
McCarthy K; Laban C; McVittie CJ; Ogunkolade W; Khalaf S; Bustin S; Carpenter R; Jenkins PJ
Anticancer Res; 2009 Oct; 29(10):3785-90. PubMed ID: 19846909
[TBL] [Abstract][Full Text] [Related]
9. Detection and analysis of apoptosis in breast and ovarian cancer subjects--genetic studies.
Kozłowska E; Romanowicz-Makowska H; Zadrozny M; Mankiewicz J; Szyłło K; Pertyński T; Kulig A; Smolarz B
Pol J Pathol; 2003; 54(1):25-9. PubMed ID: 12817877
[TBL] [Abstract][Full Text] [Related]
10. Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52.
Shehata M; Bièche I; Boutros R; Weidenhofer J; Fanayan S; Spalding L; Zeps N; Byth K; Bright RK; Lidereau R; Byrne JA
Clin Cancer Res; 2008 Aug; 14(16):5050-60. PubMed ID: 18698023
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
[TBL] [Abstract][Full Text] [Related]
12. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
Arnes JB; Bégin LR; Stefansson I; Brunet JS; Nielsen TO; Foulkes WD; Akslen LA
J Clin Pathol; 2009 Feb; 62(2):139-46. PubMed ID: 18682421
[TBL] [Abstract][Full Text] [Related]
13. A comparison of folic acid deficiency-induced genomic instability in lymphocytes of breast cancer patients and normal non-cancer controls from a Chinese population in Yunnan.
Wang X; Wu X; Liang Z; Huang Y; Fenech M; Xue J
Mutagenesis; 2006 Jan; 21(1):41-7. PubMed ID: 16339195
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of TopBP1 in breast cancer.
Going JJ; Nixon C; Dornan ES; Boner W; Donaldson MM; Morgan IM
Histopathology; 2007 Mar; 50(4):418-24. PubMed ID: 17448016
[TBL] [Abstract][Full Text] [Related]
15. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
16. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
17. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
18. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
[TBL] [Abstract][Full Text] [Related]
20. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression.
Perera CN; Chin HG; Duru N; Camarillo IG
J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]